“Drug survival and reasons for discontinuation of the first course of biological therapy in 301 juvenile idiopathic arthritis patients”, Reumatismo, vol. 65, no. 6, pp. 278–285, Mar. 2014, doi: 10.4081/reumatismo.2013.682.